- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04752553
Pros and Cons of Telemedicine in Diagnosis and Management
Studieoversikt
Status
Detaljert beskrivelse
Telemedicine "healing at a distance" Telemedicine has many advantages especially in time of pandemics for both doctors and patients, low cost and easily accessibility. Pandemics especially COVID 19 has radically change the medical team thoughts about the telemedicine. It can decrease the exposure of the medical team to infection and expected by some of the medical team to be very beneficial if done in good and legal manner. Although, telemedicine has many advantages, also has many disadvantages and medicolegal problems, breakdown in the relationship between medical teams and patients, mis diagnosis or wrong treatment. There are many legal and ethical aspects of telemedicine. These include the medical responsibilities, the confidentiality and privacy of the patients can not be maintained, the jurisdictional problems. Shortage of medical practitioners and specialists, shortage of internet facilities, low education levels in some patients all are problems facing the telemedicine in developing countries. The evolution of telemedicine poses a series of legal problems ranging from the profiles on the subject of authorization and accreditation to those concerning the protection of patient confidentiality, the definition and solution of which, in the absence of specific regulatory provisions, is mainly left to the assessment of compatibility of the practices adopted so far, with the general regulatory framework.
This research will be done to clarify the role of telemedicine, and if it has a share hand or the upper hand if compared with traditional medicine.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
-
Assiut, Egypt, 71515
- heba Yassa
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- doctors of all specialty
- Patients
- police man and who work in law
Exclusion Criteria:
- No exclusion criteria
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
- To provide an overview about the pros and cons of the telemedicine in Egypt especially in the period of the COVID 19 pandemic.
Tidsramme: 6 months
|
describe the pros and cons of the telemedicine
|
6 months
|
|
- To assess the impact of telehealth on clinical outcomes from the view of the doctors, patients.
Tidsramme: 6 months
|
list the impact of telehealth and telemedicine on doctors and patients
|
6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
- To evaluate the opinion of the law and the malpractice problems that can face doctors due to the use of telemedicine.
Tidsramme: one year
|
List the law opinion about the telemedicine
|
one year
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Ferorelli D, Nardelli L, Spagnolo L, Corradi S, Silvestre M, Misceo F, Marrone M, Zotti F, Mandarelli G, Solarino B, Dell'Erba A. Medical Legal Aspects of Telemedicine in Italy: Application Fields, Professional Liability and Focus on Care Services During the COVID-19 Health Emergency. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720985055. doi: 10.1177/2150132720985055.
- Durupt M, Bouchy O, Christophe S, Kivits J, Boivin JM. [Telemedicine in rural areas: general practitioners' representations and experiences]. Sante Publique. 2016 Oct 19;28(4):487-497. French.
- Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. Natl Med J India. 2018 Jul-Aug;31(4):215-218. doi: 10.4103/0970-258X.258220.
- Vidal-Alaball J, Acosta-Roja R, Pastor Hernandez N, Sanchez Luque U, Morrison D, Narejos Perez S, Perez-Llano J, Salvador Verges A, Lopez Segui F. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria. 2020 Jun-Jul;52(6):418-422. doi: 10.1016/j.aprim.2020.04.003. Epub 2020 Apr 17.
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AssiutU1234
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .